1. Association between polymorphic markers in candidate genes and the risk of manifestationof endocrine ophthalmopathy in patients with Graves’ disease
- Author
-
N. S. Martirosian, L. V. Trukhina, A M Burdennyy, O. G. Panteleeva, N. A. Petunina, V V Nosikov, and S. V. Saakyan
- Subjects
Genetic Markers ,0301 basic medicine ,History ,Candidate gene ,polymorphic genetic markers ,Genotype ,Endocrinology, Diabetes and Metabolism ,Graves' disease ,lcsh:Medicine ,chemical and pharmacologic phenomena ,Polymorphism, Single Nucleotide ,03 medical and health sciences ,Gene Frequency ,Humans ,Medicine ,Genetic Predisposition to Disease ,Allele ,Gene ,Alleles ,endocrine ophthalmopathy ,business.industry ,lcsh:R ,General Medicine ,medicine.disease ,graves’ disease ,Graves Disease ,Genotype frequency ,Graves Ophthalmopathy ,030104 developmental biology ,Genetic marker ,Case-Control Studies ,Immunology ,CTLA4 Gene ,Family Practice ,business - Abstract
Aim. To analyze the association between the polymorphic markers in CTLA4, TNF, IL10 and IL16 genes and the risk of manifestation of endocrine ophthalmopathy (EO) in patients with Graves’ disease (GD). Materials and methods. Case-control study included 248 patients with GD. Using polymerase chain reaction we studied the distribution of alleles and genotypes of polymorphic markers such as A60G (rs3087243) in CTLA4 gene, G(-308)A (rs1800629) in TNF gene, G(-1082)A (rs1800896) in IL10 gene, T3249C (rs4778641) in IL16 gene among 141 patients with Graves’ disease and EO and 107 patients with GD without EO. Results and discussion. The frequencies of A alleles and the AA genotypes were significantly increased and the frequencies of G alleles and the GG genotype polymorphic markers rs3087243 of CTLA4 gene and rs1800896 of IL10 gene, as well as the GG genotype polymorphic marker rs1800629 of TNF gene were reduced in patients with GD and EO. The polymorphism in CTLA4 gene was also associated with the activity and the severity of EO. The comparative analysis of the allele and genotype frequency distribution of polymorphic markers of IL16 gene did not show the significant difference. Conclusion. The risk of manifestation and the development of EO in patients with Graves’ disease can be caused by not only environmental, but also genetic risk factors.
- Published
- 2018